Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients

Journal of Neuro-Oncology

Volumn 94, Issue 2, 2009, Pages 213-219

  Sun, Boqian ^a   Chu, Dake ^b   Li, Wei ^a   Chu, Xiaodan ^a   Li, Yunming ^b   Wei, Dun ^a   Li, Haiping ^a  

^a BEIHUA UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Myc; NDRG 1; Progression; Survival

Indexed keywords

MESSENGER RNA; MYC PROTEIN; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; N MYC DOWNSTREAM REGULATED GENE 1; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; TUMOR GROWTH; WESTERN BLOTTING;

BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; SURVIVAL RATE;

EID: 68949093646     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9859-7     Document Type: Article

References (35)

1. Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3(3):255-268. doi: 10.1111/ j.1750-3639.1993.tb00752.x
2. Wakimoto H, Aoyagi M, Nakayama T (1996) Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 77(2):373-380. doi: 10.1002/ (SICI)1097-0142(19960115)77:2<373::AID-CNCR21>3.0.CO;2-Y
3. Pollack IF (1994) Current concepts in the diagnosis and treatment of pediatric brain tumors. N Engl J Med 331(22):1500-1507. doi: 10.1056/ NEJM199412013312207
4. Kleihues P, Cavenee WK (2000) Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer. Lyon, France
5. Mahaley MS Jr, Mettlin C, Natarajan N et al (1989) National survey of patterns of care for brain-tumor patients. J Neurosurg 71(6):826-836
6. Walker MD, Green SB, Byar DP et al (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303(23):1323-1329
7. Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109(1):93-108. doi: 10.1007/s00401-005-0991-y
8. Shimono A, Okuda T, Kondoh H (1999) N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 83(1-2):39-52. doi: 10.1016/ S0925-4773(99)00025-8
9. Okuda T, Kondoh H (1999) Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. Biochem Biophys Res Commun 266(1):208-215. doi: 10.1006/bbrc.1999.1780
10. van Belzen N, Dinjens WN, Diesveld MP et al (1997) A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77(1):85-92
11. Zhang J, Chen S, Zhang W et al (2008) Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region. Gene 417(1-2):5-12. doi: 10.1016/j.gene.2008.03.002
12. Qu X, Zhai Y, Wei H et al (2002) Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229(1-2):35-44. doi: 10.1023/A:1017934810825
13. Zhou RH, Kokame K, Tsukamoto Y et al (2001) Characterization of the human NDRG gene family: A newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73(1):86-97. doi: 10.1006/geno.2000.6496
14. van Belzen N, Dinjens WN, Eussen BH et al (1998) Expression of differentiation-related genes in colorectal cancer: Possible implications for prognosis. Histol Histopathol 13(4):1233-1242
15. Kalaydjieva L, Nikolova A, Turnev I (1998) Hereditary motor and sensory neuropathy-Lom, a novel demyelinating neuropathy associated with deafness in gypsies: Clinical, electrophysiological and nerve biopsy findings. Brain 121(Pt 3):399-408. doi: 10.1093/brain/121.3.399
16. Lachat P, Shaw P, Gebhard S et al (2002) Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118(5):399-408. doi: 10.1007/s00418-002-0460-9
17. Bandyopadhyay S, Pai SK, Gross SC et al (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63(8):1731-1736
18. Guan RJ, Ford HL, Fu Y et al (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60(3):749-755
19. Cangul H (2004) Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 5:27. doi: 10.1186/1471-2156-5-27
20. Cangul H, Salnikow K, Yee H et al (2002) Enhanced expression of a novel protein in human cancer cells: A potential aid to cancer diagnosis. Cell Biol Toxicol 18(2):87-96. doi: 10.1023/A:1015376032736
21. Kokame K, Kato H, Miyata T (1998) Nonradioactive differential display cloning of genes induced by homocysteine in vascular endothelial cells. Methods 16(4):434-443. doi: 10.1006/meth.1998.0698
22. Taketomi Y, Sugiki T, Saito T et al (2003) Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells. Biochem Biophys Res Commun 306(2):339-346. doi: 10.1016/ S0006-291X(03)00942-2
23. Agarwala KL, Kokame K, Kato H et al (2000) Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. Biochem Biophys Res Commun 272(3):641-647. doi: 10.1006/bbrc.2000.2833
24. Piquemal D, Joulia D, Balaguer P et al (1999) Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim Biophys Acta 1450(3):364-373. doi: 10.1016/ S0167-4889(99)00056-7
25. Kyuno J, Fukui A, Michiue T et al (2003) Identification and characterization of Xenopus NDRG1. Biochem Biophys Res Commun 309(1):52-57. doi: 10.1016/S0006-291X(03)01522-5
26. Gomez-Casero E, Navarro M, Rodriguez-Puebla ML et al (2001) Regulation of the differentiation-related gene Drg-1 during mouse skin carcinogenesis. Mol Carcinog 32(2):100-109. doi: 10.1002/mc.1069
27. Bandyopadhyay S, Pai SK, Hirota S et al (2004) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23(33):5675-5681. doi: 10.1038/sj.onc.1207734
28. Shah MA, Kemeny N, Hummer A et al (2005) Drg1 expression in 131 colorectal liver metastases: Correlation with clinical variables and patient outcomes. Clin Cancer Res 11(9):3296-3302. doi: 10.1158/ 1078-0432.CCR-04-2417
29. Li J, Kretzner L (2003) The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell. Mol Cell Biochem 250(1-2):91-105. doi: 10.1023/A:1024918328162
30. Bishop JM, Eilers M, Katzen AL, Kornberg T, Ramsay G, Schirm S (1991) MYB and MYC in the cell cycle. Cold Spring Harb Symp Quant Biol 56:99-107
31. Cowling VH, Cole MD (2006) Mechanism of transcriptional activation by the Myc oncoproteins. Semin Cancer Biol 16(4):242-252. doi: 10.1016/ j.semcancer.2006.08.001
32. Lee LA, Dang CV (2006) Myc target transcriptomes. Curr Top Microbiol Immunol 302:145-167. doi: 10.1007/3-540-32952-8_6
33. Brown RS, Wahl RL (1993) Overexpression of Glut-1 glucose transporter in human breast cancer: An immunohistochemical study. Cancer 72(10):2979-2985. doi: 10.1002/ 1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X
34. Koshiji M, Kumamoto K, Morimura K et al (2007) Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity. World J Gastroenterol 13(20):2803-2810
35. Chua M-S, Sun H, Cheung ST et al (2007) Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 20:76-83. doi: 10.1038/modpathol.3800711